These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34264514)

  • 1. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
    Waqar SHB; Khan AA; Memon S
    Int J Hematol; 2021 Nov; 114(5):626-629. PubMed ID: 34264514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.
    Hammami E; Lamarque M; Aujoulat O; Debliquis A; Drénou B; Harzallah I
    Lab Med; 2022 Nov; 53(6):e145-e148. PubMed ID: 35482291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
    Saluja P; Gautam N; Yadala S; Venkata AN
    Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.
    Yoshida K; Sakaki A; Matsuyama Y; Mushino T; Matsumoto M; Sonoki T; Tamura S
    Intern Med; 2022 Feb; 61(3):407-412. PubMed ID: 34803105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.
    Long Z; Jiang S; Xin H; Zhang L; Lu R; Liu F; Xu Y; Wang L; Wang J; Zhang X; Liao H; Shi J; Yan X; Zhu X; Shao R; Li Z; Zhu Y; Yan H; Wu J; Fang C; Xi X; Shi X
    Front Med; 2024 Aug; 18(4):744-751. PubMed ID: 38958922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
    Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D
    J Thromb Haemost; 2021 Sep; 19(9):2314-2317. PubMed ID: 34105247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
    Vorster L; Kirk SE; Muscal E; Despotovic JM; Cohen CT; Sartain SE
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29681. PubMed ID: 35373880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
    Fang F; Tse B; Pavenski K
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection.
    Mei S; Feng Y; Cui L; Chen J; Mao Z; Zhao X; Mei C; Qian Y
    BMC Nephrol; 2022 Dec; 23(1):400. PubMed ID: 36513992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
    Giuffrida G; Condorelli A; Di Giorgio MA; Markovic U; Sciortino R; Nicolosi D; Di Raimondo F
    Haematologica; 2022 Apr; 107(4):1008-1010. PubMed ID: 34382388
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
    Ruhe J; Schnetzke U; Kentouche K; Prims F; Baier M; Herfurth K; Schlosser M; Busch M; Hochhaus A; Wolf G
    Ann Hematol; 2022 Mar; 101(3):717-719. PubMed ID: 34309715
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine.
    Herrman E; Ghimire B; Chisti MM
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
    Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
    BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID 19 infection associated with thrombotic thrombocytopenic purpura.
    Dhingra G; Maji M; Mandal S; Vaniyath S; Negi G; Nath UK
    J Thromb Thrombolysis; 2021 Aug; 52(2):504-507. PubMed ID: 33904053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review.
    Tehrani HA; Darnahal M; Vaezi M; Haghighi S
    Int Immunopharmacol; 2021 Apr; 93():107397. PubMed ID: 33524803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.
    Yocum A; Simon EL
    Am J Emerg Med; 2021 Nov; 49():441.e3-441.e4. PubMed ID: 33980419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review.
    Kornowski Cohen M; Sheena L; Shafir Y; Yahalom V; Gafter-Gvili A; Spectre G
    Acta Haematol; 2021; 144(6):678-682. PubMed ID: 33895748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.
    Ntelis S; Champ K
    J Community Hosp Intern Med Perspect; 2022; 12(4):80-84. PubMed ID: 36262899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.